Target intelligence / Profile preview

Hyaluronic acid (HA) (HA)

Target
HA
Molecular classification
Glycosaminoglycan, Polysaccharide, Extracellular matrix component
01

Overview

Hyaluronic acid (HA) is a high-molecular-weight, non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, found extensively throughout the extracellular matrix of connective, epithelial, and neural tissues (PubChem CID 24759). It plays a fundamental role in maintaining tissue hydration and osmotic balance due to its exceptional water-binding capacity, while also providing essential lubrication in synovial joints. Beyond its structural contributions, HA serves as a dynamic signaling molecule by interacting with cell surface receptors such as CD44 and the Receptor for Hyaluronan-Mediated Motility (RHAMM), which regulate cell proliferation, migration, and inflammatory responses (PubMed PMID: 30235439). In pathological conditions like cancer, the over-accumulation of HA in the tumor stroma increases interstitial fluid pressure, creating a physical barrier that hinders the delivery and efficacy of chemotherapeutic agents (PubMed PMID: 29439110). Therapeutic interventions targeting HA include the use of hyaluronidases to degrade the matrix and improve drug penetration, as well as the administration of exogenous HA as a viscosupplement to restore joint function in osteoarthritis (StatPearls NBK482440).

Other names
HyaluronanHyaluronateSodium hyaluronateD-glucuronic acid-N-acetyl-D-glucosamine polymer
02

Mechanism of action

Enzymatic degradation of hyaluronic acid to reduce interstitial fluid pressure and enhance drug diffusion; supplementation of synovial fluid to provide mechanical lubrication and shock absorption; inhibition of hyaluronan synthase to prevent pathological accumulation.

03

Biological functions

Cell adhesionCell migrationTissue hydrationLubricationWound healingSignal transductionExtracellular matrix organization
04

Disease associations

CancerOsteoarthritisInflammationLiver fibrosisDermatological disordersEdema
05

Safety considerations

Hypersensitivity reactionsInjection site pain and swellingPotential for pro-inflammatory effects from low-molecular-weight degradation fragmentsTheoretical risk of promoting tumor metastasis through increased cell motility
06

Interacting drugs

Hyaluronidase

5 more in the full profile.

07

Biomarkers

Serum hyaluronic acid levelsHyaluronic acid fragment size distributionCD44 expression levels

Beyond the preview

Go deeper on Hyaluronic acid (HA) (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronic acid (HA) (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call